Raymond James Financial Services Advisors, Inc. Volitionrx LTD Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 02, 2021	SELL	$2.98 - $3.48 $40,930 - $47,797	-13,735 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$3.01 - $3.78 $41,342 - $51,918	13,735 New	13,735 $45,000

Others Institutions Holding VNRX

# of Institutions

Shares Held

21.2M

Call Options Held

Put Options Held

Lagoda Investment Management, L.P. New York, NY

10.2M
Shares

$5.5 Million
3.7% of portfolio
Armistice Capital, LLC New York, NY

8.21M
Shares

$4.43 Million
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

762K
Shares

$411,453
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

706K
Shares

$381,272
0.0% of portfolio
Black Rock Inc. New York, NY

516K
Shares

$278,679
0.0% of portfolio

View Full List

About VOLITIONRX LTD

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $30.9M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

More about VNRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account